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ABSTRACT
The identity of cells within squamous epithelia that represent primary targets in acute graft-versus-host
disease (GVHD) has been an enigma. Murine effector T cells implicated in the alloresponse by V comple-
mentarity-determining region-3 spectratype analysis were detected with a V-specific monoclonal antibody
within discrete microdomains of tongue (lingual) squamous epithelium. These microdomains, termed rete-like
prominences (RLPs), are similar to the rete ridges of human skin. Cells forming the basal layer of RLPs and of
human skin rete ridges were shown to express a distinctive pattern of keratin expression defined by antibodies
to cytokeratin 15 (K15). In experimental murine GVHD elicited across minor histocompatibility antigen
barriers (miHA), early lesions involved selective apoptosis and loss of K15 staining within lingual RLPs. An
in vitro organ culture model designed to investigate target cell injury by short-term exposure to tumor necrosis
factor- and interleukin-1, mediators relevant to GVHD, showed a similar pattern of apoptosis and loss of
K15 reactivity within RLPs. In aggregate, these findings establish a novel cytoskeletal marker for target
epithelial subpopulations that should facilitate evaluation of mechanisms of host cell injury in GVHD. These
data may also enable the development of therapeutic approaches to abrogate disease at the level of target cell
blockade.
© 2003 American Society for Blood and Marrow Transplantation
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The pathogenesis of acute graft-versus-host dis-
ase (GVHD) involves at least 3 distinct, yet interre-
ated, evolutionary phases: allostimulation, effector
ell homing, and tissue-speciﬁc targeting [1]. Al-
hough recent cellular and molecular approaches de-
igned to abrogate GVHD have focused on inhibiting
athways that mediate allostimulation and homing,
ittle is known with respect to blockade at the level of
ost cell targeting. This is in large part related to the
act that the precise identity of host cells that are
argeted in GVHD has not yet been resolved. Host
ell targeting in both human and experimental d
B&MTVHD involves epithelial injury elicited by speciﬁc
ubpopulations of allostimulated donor T cells that
ecrete cytokines systemically and home selectively to
iver, gut, skin, and related squamous epithelia. The
issue damage that results has been shown to involve
nduction of epithelial apoptosis, as opposed to necro-
is [2,3]. However, only certain subpopulations of host
pithelial cells are vulnerable to apoptotic injury. In
quamous epithelia (eg, skin and tongue), cells that
eside in the basal layer are preferentially targeted in
VHD. Moreover, histopathologic evidence suggests
hat early targeting preferentially affects basal cell
ubpopulations that are concentrated in the tips ofoi:10.1016/S1083-8791(03)00288-XG
s
s
liscrete downgrowths of the epidermis (rete ridges)
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[4], in analogous rete-like prominences (RLPs) of dor-
sal tongue [2,5,6], and in bulge regions of hair follicles
[7,8]. It is interesting to note that epithelial cell pop-
ulations in these microanatomical domains also have
features of stem cells involved in self-renewal and
repair [9-11].
Experimental murine models in which GVHD is
elicited exclusively across minor histocompatibility
antigen (miHA) disparities have proven both informa-
tive and relevant to human disease [12-15]. However,
murine skin is of limited value in elucidating speciﬁc
microanatomic domains targeted by effector pathways
because the epidermis is devoid of the rete ridges
implicated as possible primary sites of injury in human
skin. Squamous epithelium of murine dorsal tongue,
however, possesses structurally similar RLPs that also
represent sites of selective injury in GVHD [2,5]. We
have found that in disease produced across miHA
barriers, RLPs are informative surrogates for epider-
mal rete ridges in studies focused at determining how
cellular and molecular heterogeneity within the basal
cell layer may relate to target cell-selective cytotoxic-
ity [2].
A prerequisite to understanding the mechanism or
mechanisms whereby speciﬁc epithelial subpopula-
tions within the basal layer are preferentially targeted
in GVHD is to identify markers selectively expressed
by these cells. Recently, a monoclonal antibody (mAb;
clone C8/144B) that recognizes human cytokeratin 15
(K15) was used to delineate the bulge region of human
hair follicles [16], a known site of early host epithelial
cell targeting in GVHD. However, other epithelial
subpopulations that are targeted in GVHD (eg, epi-
dermis) did not show K15 expression by the methods
used. Although discontinuous epidermal reactivity for
K15 in human, murine, and sheep epidermis has been
noted by other observers [17,18], correlation with a
speciﬁc structural domain or site of immune targeting
has not been made. In this study, we have identiﬁed
methodologies that permit detection of K15 epithe-
lial domains in human and murine epidermis, as well
as in murine dorsal tongue. In human skin, these
K15 regions correspond to rete ridges, and in mu-
rine tongue, they correspond to RLPs. Additionally,
our data indicate that K15 RLPs are (1) sites of
inﬁltration by allospeciﬁc T cells in experimental mu-
rine GVHD, (2) microanatomic sites of early apopto-
tic injury, and (3) regions preferentially vulnerable to
cytokine-mediated apoptosis in an in vitro organ cul-
ture model of GVHD-like cytotoxicity. It is con-
cluded that basal cells are heterogeneous with regard
to cytokeratin phenotype and related cytotoxic target-
ing characteristics. Further evaluation of K15 RLPs
should aid in elucidating and potentially abrogating
targeting pathways that play critical roles in patient
morbidity and mortality.
MATERIALS AND METHODS
Mice
Two major histocompatibility complex (MHC)–
matched, miHA-disparate strain combinations—
B10.D2/oSnJ (B10.D2) 3 DBA/2Ncr (DBA) (H2d)
and C57BL/6ByJ (B6) 3 C.B10-H2b/LiMcdJ
(BALB.B) (H2b)—were used to generate GVHD me-
diated by CD4 T cells. B10.D2 and B6 male mice
(Jackson Laboratory, Bar Harbor, ME) between the
ages of 7 and 12 weeks were used as donors, and DBA
(NCI Animal Production Program, Bethesda, MD)
and BALB.B (Jackson Laboratory) male mice between
the ages of 9 and 16 weeks were used as recipients.
BALB/cAnNTac-Rag2tmlN12 (severe combined im-
munodeﬁciency disease; SCID) immunodeﬁcient mice
(Taconic, Germantown, NY) were used for initial
screening of cytokeratin expression because the ab-
sence of endogenous antibody minimized background
staining when mouse mAbs were used. All mice were
housed in a sterile environment in microisolator cages
(Lab Products, Maywood, NJ) and provided with au-
toclaved food and water ad libitum.
Antibodies
Anti–Thy-1.2 (J1j; ascites ﬂuid; rat immunoglob-
ulin [Ig]M) and anti-CD8 (3.168; rat IgM) mAbs were
used along with guinea pig complement (C; Rockland,
Boyertown, PA) for cell subset depletion. Goat anti-
mouse IgG antibody (ICN Immunobiologicals, Costa
Mesa, CA) was used for B-cell panning.
The primary mAbs used for immunostaining were
rat anti-murine CD3 (Antigenix America, Huntington
Station, NY); rat anti-murine CD4, CD8, and I-Ab,d,q;
biotinylated mouse anti-murine V8.1,8.2 T-cell re-
ceptor (TCR) and V5.1,5.2 TCR (BD Pharmingen,
San Diego, CA); and mouse anti-human K14 (Bio-
genex, San Ramon, CA), K15, clone LHK15 (Lab
Vision, Fremont, CA), and clone C8/144B (Dako,
Carpinteria, CA). For evaluation of GVHD and lin-
gual organ culture tissue samples, LHK15 mAb was
biotinylated by using a BiotinTag Micro Biotinylation
Kit (Sigma Chemical, St. Louis, MO). Control anti-
bodies were rat IgG2a (BD Pharmingen), mouse IgG1
negative control (Dako), or biotinylated mouse anti-
human CD45 mAb (BD Pharmingen).
For ﬂow cytometry, rabbit polyclonal anti-mouse
K14 antibody directly conjugated to ﬂuorescein iso-
thiocyanate (FITC; Covance Research Products,
Richmond, CA) was used, along with donkey anti-
mouse F(ab)2 antibody conjugated to R-phyco-
erythrin (PE; Accurate Scientiﬁc, Westbury, NY) for
indirect detection of K15 (clone LHK15) mAb bind-
ing.
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Preparation of Donor Cells
Bone marrow cells were obtained from the femurs
and tibiae of donor mice by ﬂushing with phosphate-
buffered saline (PBS) supplemented with 0.1% bovine
serum albumin (BSA; Sigma) and anti–T cell–de-
pleted bone marrow (ATBM) was prepared by incu-
bation with J1j mAb (1:100) and guinea pig comple-
ment (1:25) for 45 minutes at 37°C. T cell–enriched
donor cell populations were prepared by treating
pooled spleen and lymph node cells with Gey’s bal-
anced salt lysing solution containing 0.7% NH4Cl,
followed by panning on plastic petri dishes precoated
with goat anti-mouse IgG antibody (40 g/mL) for 1
hour at 4°C to remove B cells. To purify CD4 T
cells, T cell–enriched preparations were treated with
anti-CD8 mAb (1:50) plus C (1:25) for 45 minutes at
37°C initially and again for 30 minutes with a wash in
between. Cells were phenotyped by ﬂow cytometry
and were routinely found to be negative for CD8
expression.
Bone Marrow Transplantation and GVHD
Induction
Recipient mice were lethally irradiated with a
Gammacell (J.L. Shephard, San Fernando, CA) ce-
sium 137 source (10 Gy at 1.3 Gy/min). Approxi-
mately 6 hours later, these recipients were injected
intravenously with donor cells via the tail vein. The
inoculum consisted of either ATBM cells (2  106)
alone, as a negative disease control, or a mixture of
ATBM (2  106) and donor puriﬁed CD4 T cells
(5  106 cells for B10.D2 3 DBA and 2  107 cells
for B6 3 BALB.B strain combinations). Morbidity
and mortality of mice were monitored daily, and
weights were monitored twice weekly.
Tissue Samples
All tissue samples were snap-frozen in Optimal
Cutting Temperature medium (Miles Laboratories,
Elkhart, IN) for immunohistochemical or immunoﬂu-
orescent analyses with 5-m cryostat sections and/or
were collected in 10% phosphate-buffered formalin
(Fisher Scientiﬁc, Malvern, PA) for routine parafﬁn
section histology. Normal human skin samples (facial,
breast, and forearm) were collected from routine sur-
gical procedures. Normal SCID back skin and tongue
tissues and DBA, B6, B10.D2, and BALB.B tongue
tissues were used to evaluate K15 expression. ATBM
and GVHD tongue samples were collected from
BALB.B recipient mice at days 3, 7 or 11, 15, 22, and
30 after bone marrow transplantation (BMT) (3 mice
each per time point for 3 separate experiments) and
from DBA recipient mice at days 4, 7, 14, and 21 days
after BMT (3 mice each at days 4 and 7 and 2-3 mice
each at days 14 and 21 for 3 separate experiments).
V Complementarity-Determining Region-3–Size
Spectratyping
V TCR complementarity-determining region-3
(CDR3)–size spectratype analysis, a highly sensitive
reverse transcriptase–polymerase chain reaction
(PCR)–based technique, was used to identify T-cell
expansion within speciﬁc V families indicated
by overrepresentation of individual CDR3-region
lengths of V-positive TCRs, as previously described
in detail [19]. Brieﬂy, total cellular RNA was prepared
from enriched CD4 T cells (collected 5 days after
BMT) and homogenized in 1 mL of Ultraspec (Bio-
tecx Laboratories, Houston, TX). The poly(A) por-
tion of the total RNA was converted into complemen-
tary DNA by using oligo(dT) as a primer for reverse
transcription. PCR was performed by using a 32P-
labeled constant primer (Cb) and a V primer spe-
ciﬁc for each V family to be analyzed. All the primers
used have been previously described [20,21]. PCR
products were electrophoresed on a 6% acrylamide
sequencing gel. Sequencing gels were dried, and au-
toradiography was generally performed for 15 hours
at room temperature (RT) without intensifying
screens. Densitometric scanning of autoradiographs
was performed on a Personal Densitometer SI by
using ImageQuant software (Molecular Dynamics,
Sunnyvale, CA).
Immunohistochemical Methods
Immunohistochemistry was performed with a
standard 3-step biotin-avidin–horseradish peroxidase
method for all unconjugated rat and mouse primary
mAbs. Brieﬂy, cryostat sections or cytospin prepara-
tions were acetone-ﬁxed for 5 minutes at 20°C,
air-dried, and incubated with one of the following
mAbs: rat anti-mouse CD3 (1:50), CD4 (1:400), CD8
(1:400), I-Ab,d,q (1:500), and rat IgG2a control (1:50)
or mouse anti-human K14 (1:50), K15, clone LHK15
(1:50 to 1:1000), or clone C8/144B (1:5 to 1:20) and
mouse IgG1 control (1:50) for 1 to 1.5 hours at RT or
overnight at 4°C. Secondary antibodies (1:200) were
biotinylated rabbit anti-rat, mouse-adsorbed (Vector
Laboratories, Burlingame, CA) for rat primary mAb
and biotinylated horse anti-mouse (Vector) for mouse
mAb, followed by biotin-avidin–horseradish peroxi-
dase as the third layer. Immunoreactivity was revealed
by using 3,3-diaminobenzidine (Sigma), Vector VIP
(Vector), or NovaRED (Vector) chromagen. For im-
munoﬂuorescent detection with anti-human K14 and
K15 mAbs, SCID mouse tongue sections were ﬁxed in
acetone and then incubated with primary mAb (1:50)
for 1.5 hours at RT followed by donkey anti-mouse
Cy2 conjugate (1:25; Accurate Scientiﬁc) for 30 min-
utes and examined with a Nikon (Melville, NY) Mi-
crophot SA ﬂuorescent microscope attached to an
Optronics (Goleta, CA) digital camera. For immuno-
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detection with biotinylated anti-V8 and anti-V5
(1:600), an avidin-biotin blocking kit (Vector) was
used before primary mAb incubation, followed by
ampliﬁcation with the Renaissance TSA-Indirect Kit
(NEN Life Science Products, Boston, MA) and 3,3-
diaminobenzidine development for 3 minutes only.
For detection of K15 expression in non-SCID mouse
tissues (ie, GVHD tissues and lingual organ culture),
sections were ﬁxed with 4% paraformaldehyde (PF;
Electron Microscopy Sciences, Ft. Washington, PA)
in PBS for 10 minutes at 4°C, washed with PBS 3,
incubated with 0.1% Triton X-100 (Sigma) in PBS for
10 minutes, washed and blocked with an avidin-biotin
blocking kit for 20 to 25 minutes each (Vector), and
then incubated with either biotinylated anti-human
K15 mAb (LHK15; 1:50) or biotinylated anti-human
CD45 irrelevant control mAb (1:5) for 1.5 hours at
RT. After washing, primary antibody binding was
detected with streptavidin/horseradish peroxidase
conjugate (1:50; Vector) for 30 minutes at RT and
developed by using NovaRED substrate. Sections
were counterstained lightly with Gill No. 1 hematox-
ylin (Fisher) or with methyl green (Biogenex) when
Vector VIP substrate was used. In experiments to
assess spatial relationships between K15, CD4, and
terminal deoxynucleotidyl transferase–mediated de-
oxyuridine triphosphate nick-end labeling (TUNEL;
see below) expression, serial sections separated by 5
m were used.
Detection of Apoptotic Cells by TUNEL
Cryostat sections were ﬁxed with 4% PF for 10
minutes at 4°C, washed 3 times with PBS for 5 min-
utes each, and permeabilized with 70% ethanol at
20°C for 5 minutes. After 3 deionized water washes,
sections were incubated with terminal deoxynucleoti-
dyl transferase enzyme in reaction buffer (Serologi-
cals, Norcross, GA) at a ratio of 1 part enzyme to 2
parts buffer at 37°C in a humidiﬁed chamber for 1
hour. Sections were then washed and incubated with
sheep anti-digoxigenin horseradish peroxidase Fab (1:
50; Roche Molecular Biochemicals, Indianapolis, IN)
for 30 minutes at RT, developed with NovaRED
substrate, and counterstained, as described previously.
Light and Electron Microscopy
All tissue samples were analyzed by routine light
microscopy (hematoxylin and eosin staining). RLPs
were deﬁned as epithelial downgrowths bordered by
interdigitating papillae formed by submucosal con-
nective tissue. The border between RLP and inter-
RLP basal cells was operationally designated as the
midpoint of the distance between the top of the sub-
mucosal connective tissue papilla and the tip of the
adjacent RLP. Apoptotic cells, as inferred by conven-
tional staining and conﬁrmed by TUNEL, were iden-
tiﬁed qualitatively by 2 independent observers and
consisted of squamous epithelial cells with darkly
stained pyknotic or fragmented nuclei surrounded by
hypereosinophilic cytoplasm [2,14].
For ultrastructural analysis, selected murine
tongue samples were ﬁxed in Karnovsky’s II ﬁxative
[22] at 4°C and stored until further processing. After
washing with 0.1 M cacodylate buffer, pH 7.4, tissue
samples were postﬁxed with 2% osmium tetroxide,
dehydrated through graded ethanols with propylene
oxide as the ﬁnal step, and embedded in Taab Epon
812 (Marivac, Nova Scotia, Canada). One-micrometer
sections were stained with 0.5% toluidine blue in
0.5% sodium borate, and areas were evaluated for
further analysis. Ultrathin sections were cut on a Leica
(Wetzlar, Germany) Ultracut UCT ultramicrotome,
poststained with uranyl acetate followed by bismuth
subnitrate, and viewed on a Hitachi (Gaithersburg,
MD) H7000 electron microscope.
Isolation of Murine Lingual Basal Epithelial Cells
Tongue tissue was collected from killed mice and
placed in Dulbecco’s modiﬁed Eagle’s medium 1:1
mixture with Ham’s F12 (DMEM/F12; Life Technol-
ogies, Grand Island, NY) containing 100 IU of peni-
cillin and 100 g of streptomycin per milliliter (P/S;
Mediatech, Herndon, VA). Thin strips of tongue tis-
sue were prepared and placed at 4°C in DMEM/F12
containing dispase 2 mg/mL (Life Technologies). Af-
ter overnight incubation, epithelial sheets were col-
lected by separating the epithelium from the underly-
ing connective tissue with the aid of a dissecting
microscope and ﬁne forceps. Epithelial sheets were
then incubated in 0.25% trypsin/0.1% EDTA (Media-
tech) and agitated for 5 minutes at RT followed by an
additional 5 minutes of pipetting to separate individ-
ual cells. Trypsinization was stopped by the addition
of DMEM/F12 with 10% fetal bovine serum (FBS;
Mediatech), and the cells were pelleted by centrifuga-
tion and washed with PBS. For cytospin preparation,
1% FBS was added to the cell suspension, and slides
were prepared by using a Shandon Cytocentrifuge and
stored at 80°C until use.
Flow Cytometry of Lingual Basal Cells
Isolated lingual cells were resuspended in PBS and
ﬁxed for 10 minutes at RT by the addition of an equal
volume of 2% PF. The cells were washed twice with
PBS, and approximately 400 000 lingual epithelial
cells were aliquoted per well of a 96-well microtiter
plate and incubated with rabbit anti-murine K14-ﬂu-
orescein isothiocyanate conjugate (K14-F), mouse anti-
human K15 (LHK15), or K14-F plus K15 for 1.5
hours at RT in PBS containing 2% BSA and 0.025%
saponin (Sigma). After washing twice with PBS con-
taining 2% BSA, cells previously incubated with K15
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mAb were detected by using donkey anti-mouse PE
(1:25). Control cells received either buffer alone or
donkey anti-mouse PE alone. Fluorescence analysis
was performed on a Beckman Coulter XL-MCL an-
alytic cytometer (Beckman Coulter, Miami, FL) in the
Kimmel Cancer Center Flow Cytometry Facility.
Lingual Organ Culture Cytotoxicity Assay
A method to evaluate short-term effects of cyto-
kines on explants of mouse dorsal tongue was devel-
oped by modiﬁcation of an approach used previously
for embryonic rat tongue organ culture [23]. DBA
mouse tongues were collected in DMEM/F12 with
P/S, and thin strips of the dorsal surface, approxi-
mately 3 to 5 mm long by 1 to 1.5 mm deep, were
prepared with the aid of a dissecting microscope. Ex-
plants (2 per condition/time point) were then placed,
connective tissue side down, on 0.45-m HAWP mil-
lipore ﬁlter paper, 25 mm in diameter (Fisher Scien-
tiﬁc), which was supported by a fenestrated plastic
insert placed inside 60-mm petri dishes containing
DMEM/F12 with 10 % FBS and P/S, in the presence
or absence of murine tumor necrosis factor- (TNF-
), murine interleukin-1 (IL-1; Peprotech, Rocky
Hill, NJ), or both. The 60-mm petri dishes were then
placed inside 110  15 mm square petri dishes con-
taining 20 mL of sterile water and incubated at 37°C
with 5% humidity. Initial experiments were per-
formed for 24 and 48 hours, and time-course studies
were collected at 4, 8, 16, and 24 hours. Two concen-
trations of murine IL-1 plus murine TNF-, as de-
ﬁned by previously established protocols, were evalu-
ated [24,25]: IL-1 25 U/mL plus TNF- 500 U/mL
and IL-1 250 U/mL plus TNF- 2500 U/mL, as
well as IL-1 250 U/mL alone and TNF- 2500
U/mL alone. Replicate experiments were performed
to conﬁrm all results (5 separate explant experiments
were evaluated for assessment of TNF- plus IL-1
effects).
RESULTS
Induction of Acute GVHD
Two MHC-matched miHA-disparate strain com-
binations, B10.D2 3 DBA (H2d) and B6 3 BALB.B
(H2b), were used to generate GVHD mediated by
CD4 T cells. Signs of GVHD (weight loss, hunched
posture, rufﬂed fur, and histologic conﬁrmation in
skin and tongue) were present in all animals receiving
CD4 T-cell transplants, but not in animals receiving
ATBM only, as previously described [14,19,26]. Re-
cipient tissue from both strain combinations was com-
paratively evaluated by using all techniques, and
pathologic alterations proved qualitatively identical.
However, disease characteristically progressed more
rapidly in the B10.D2 3 DBA strain combination
(median survival time, 11 days) [26] than in the B63
BALB.B strain combination (median survival time, 58
days). Accordingly, the latter model was used primar-
ily for assessment of sequential T-cell homing pat-
terns.
Allospecific T Cells Selectively Infiltrate RLPs in
Experimental GVHD
Experiments were designed to determine whether
speciﬁcally allostimulated effector T cells, as opposed
to T-cell inﬁltrates in general, exhibit patterns of early
homing consistent with RLP-directed targeting. In
murine GVHD elicited across miHA barriers in which
CD4 donor T cells are known to be effectors, se-
quential immunohistochemical evaluation of dorsal
tongue revealed progressive and selective inﬁltration
of RLPs by CD4 T cells during the ﬁrst 3 weeks
after transplantation (Figure 1A-D). Because animals
that underwent transplantation received only CD4T
cells, identical patterns of RLP inﬁltration were also
observed with anti-CD3 mAb, and anti-CD8 staining
was consistently negative.
During allostimulation, speciﬁc families of T cells
deﬁned by their TCR V use become clonally ex-
panded. These overrepresented subpopulations may
be identiﬁed by V TCR CDR3-size spectratype
analysis [19]. In GVHD that develops in the B6 3
BALB.B strain combination, spectratype analysis of
CD4 T cells after transplantation revealed overrep-
resentation during allostimulation (day 5) of several
T-cell V families, including V8 (Figure 1E and 1F),
but not V5 (not shown; as previously observed [19]).
Immunohistochemistry with anti-V8.1,8.2 and anti-
V5.1,5.2 mAb revealed that V8, but not V5, T
cells preferentially inﬁltrated RLPs (Figure 1G and
1H). Both V8 and CD4 T cells were consistently
localized within most (80%) RLPs, with only rare
positively stained cells (	5%) within epithelium con-
stituting the inter-RLP regions. Of the CD4 T-cell
population at the time of peak disease activity (day 30),
60% to 75% were V8, and 	5% were V5 in
adjacent sections.
Lingual RLPs Prominently Express K15
Epithelial cells within the bulge region of human
hair follicles express K15 [16], and these regions are
targeted in GVHD [7,8]. It was thus reasoned that
other epithelial target sites (eg, murine RLPs) also
may possess a similar or distinctive cytokeratin phe-
notype. C8/144B mAb, which recognizes K15 [16],
was used with a modiﬁed immunohistochemical stain-
ing protocol. This new protocol differed from those
previously reported by (1) use of cryostat sections, (2)
ﬁxation in cold acetone or 4% PF, and (3) overnight
primary antibody incubation at 4°C. With this proto-
col, basal cells that formed rete ridges of the epidermal
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layer in control human skin showed strong cytoplas-
mic reactivity (Figure 2A and 2B), whereas cells that
formed interrete regions were either weakly positive
or negative. In addition, basal cells in the outer root
sheath and bulge region of hair follicles were also
positive for K15, as previously reported [16]. Evalua-
tion of normal mouse tissue (SCID; see Materials and
Methods) with this modiﬁed technique revealed a sim-
ilar pattern of K15 reactivity concentrated in basal
cells forming RLPs of dorsal tongue (Figure 2C and
2D). However, K15 staining of murine RLPs was less
intense and more variable than that observed for rete
ridges of human skin. Isolated clusters of basal cells
(2-4 cells) within the murine epidermis, as well as
bulge regions of hair follicles, were also positive for
K15 (Figure 2C, insets).
To improve detection of preferential K15 immu-
noreactivity within the basal cell layer, an additional
anti-K15 mAb was screened in normal mouse tissue.
LHK15, an antibody generated against the last 17
amino acids of the K15 polypeptide [17], demon-
strated markedly enhanced and consistent immunore-
activity for basal epithelial cells restricted to RLPs of
mouse tongue (Figure 2F). This pattern was con-
Figure 1. Sequential T-cell homing patterns for dorsal lingual epithelium in experimental murine GVHD. A-D, Sequential immunohisto-
chemistry at days 3, 11, 15, and 22, respectively, showing preferential involvement of RLP by T cells (arrowheads; identical patterns were
observed with anti-CD3 and anti-CD4 mAb; CD8 T cells were not detected). In control mouse tongue, the only immunoreactive
hematopoietic cells within the epithelial layer were MHC class II–positive dendritic cells localized to RLP domains (A, inset). E, V8-speciﬁc
primers were used to generate PCR products from control B6 naive splenic CD4 T cells (left) and from B6 3 BALB.B GVHD-reactive
CD4 T cells (right). F, Densitometric scans of these gel ﬁlms generated histograms to evaluate the size distribution of the CDR3 bands
between the B6 (top) and the B63 BALB.B (bottom) and revealed preferential use (skewing) of 2 bands (arrows;O.D. indicates optical density).
G, Immunohistochemistry at the time of peak disease (day 30) with anti-V8 mAb showed positive cells localized within RLPs (arrowheads),
whereas staining of adjacent sections for V5 (control) was negative (H).
D. Whitaker-Menezes et al.
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ﬁrmed in all murine strains evaluated (data not
shown). K15 basal cells consistently showed strong
staining of uniform intensity concentrated at the tips
of RLPs. This staining dissipated in basal cells form-
ing the uppermost edges of RLPs and inter-RLP do-
mains. In contrast, antibodies to K14 showed contin-
uous reactivity involving the entire basal cell layer
(Figure 2E). Trypsinized basal cell suspensions of
both human skin and murine lingual mucosa revealed
a spectrum of K15 immunoreactivity among cells in
cytospin preparations ranging from strong to negative
(Figure 2G). Flow cytometric analysis conﬁrmed this
spectrum of K15 reactivity within the K14 basal cell
layer population (Figure 2H).
Figure 2. K15 expression in normal human skin and murine lingual epithelium. A and B, K15 staining in normal human skin with clone
C8/144B mAb, which recognizes human cytokeratin 15 [16]. Strong preferential basal cell reactivity for K15 was detected in epidermal rete
ridges (A, arrows; rare individual cells in the dermis and epidermis represent normally trafﬁcking T cells expressing CD8 that are also
recognized as a K15-independent epitope by this mAb [16]). C and D, In murine lingual epithelium, immunoreactivity was detected by
C8/144B mAb in the basal cells of RLPs (C, arrows). Apparent faint suprabasal staining proved in serial sections to be an artifact of the plane
of sectioning through RLPs. In murine epidermis (C; inset, top left) and hair follicles (C; inset, top right), isolated basal cells and the follicular
bulge region were also positive (arrowheads). E, Immunoﬂuorescent detection of K14 showed uniform expression throughout the lingual basal
cell layer, whereas K15 immunoreactivity detected with anti-cytokeratin 15 mAb (clone LHK15, which identiﬁes K15 exclusively) demon-
strated strong positivity concentrated at the tips of RLPs (F). G, Cytocentrifuge preparation of isolated basal epithelial cells stained with
LHK15 mAb revealed a spectrum of reactivity from strongly positive to negative. H, This spectrum of K15 reactivity within the K14
population was also demonstrated by ﬂow cytometric analysis, where 60.8% of the K14 epithelial cells showed variable ﬂuorescent intensity
for K15. FITC indicates ﬂuorescein isothiocyanate; PE indicates phycoerythrin.
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K15-Positive RLPs Are Altered by Experimental
GVHD
A mainstay for evaluating epithelial GVHD pa-
thology in the miHA murine model has been the
detection of dyskeratotic (now known to be apoptotic)
target cells [2,13,14,27-29]. By routine light micros-
copy, apoptotic epithelial cells, distinguished by py-
knotic or fragmented nuclei and hypereosinophilic
cytoplasm, could be detected within RLPs, but not
inter-RLP regions, by days 7 to 11 (Figure 3A). These
injured cells were conﬁrmed to be apoptotic and were
consistently demonstrated to be restricted to the basal
or immediate suprabasal layers of RLPs by TUNEL
immunohistochemistry (Figure 3B). Previous studies
using immunoultrastructural approaches for correla-
tion of TUNEL with intermediate ﬁlament expres-
sion have shown such apoptotic cells to be of epithelial
origin [3]. In addition, transmission electron micros-
copy revealed lymphocyte apposition to epithelial cells
within RLPs (Figure 3C). Immunohistochemistry of
the lingual epithelium at days 4 and 7 revealed pro-
gressive inﬁltration of RLPs by CD4 T cells (Figure
3D and 3E) associated with focal loss of K15 staining
(Figure 3F and 3G). By day 7 (Figure 3E), foci where
CD4 T cells surrounded larger nonreactive cells
were detected within RLPs. In adjacent sections,
the centrally located cells in such foci proved to be
strongly reactive for K15 (Figure 3G), thus corre-
lating with the cytoarchitecture of satellitosis. In
animals receiving only ATBM transplants, tongue
samples were indistinguishable from those of nor-
mal controls, with no evidence of epithelial T-cell
inﬁltration or apoptosis by the various techniques
used.
Figure 3. Evaluation of murine GVHD lingual tissue for apoptosis, T-cell inﬁltration, and K15 expression. A, Light microscopy of
hematoxylin and eosin–stained tissue from GVHD at day 11 after BMT reveals lymphocytic inﬁltration and apparent apoptosis in RLPs
(arrow). B, Apoptosis restricted to RLPs was conﬁrmed by TUNEL immunohistochemistry (arrows). C, Transmission electron microscopy
demonstrates RLP inﬁltrated by a lymphocyte (left arrow) in apposition to an epithelial cell undergoing mitotic division (right arrow). D and
E, Immunohistochemistry for CD4 at days 4 (D) and 7 (E) after BMT with progressive inﬁltration of RLPs by CD4 T cells. Note the focus
where CD4 T cells (E; arrow) surround a centrally located nonreactive cell (E; inset). F and G, K15 expression in sections adjacent to (D)
and (E), respectively, reveals focal loss of K15 immunoreactivity (F; arrow). Note the cell strongly positive for K15 and surrounded by
nonreactive cells (G; arrow and inset), a pattern reciprocal to the inset in (E) and suggestive of satellitosis.
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TNF- and IL-1 In Vitro Mimic GVHD Effects on
K15-Positive RLPs
To determine whether RLP-restricted apoptotic
injury and loss of K15 staining could result from
cytotoxic mediators of relevance to target cell injury in
GVHD (eg, TNF- and IL-1) [30], an in vitro organ
culture model for murine tongue explantation was
developed (Figure 4; also see Materials and Methods).
The ﬁrst alterations were detected 8 hours after cul-
ture with TNF- plus IL-1 with concentrations pre-
viously established to produce biological effects in
similar explant systems [24,25,31,32]. These alter-
ations were focal and subtle (	10% of RLPs affected),
consisting of isolated TUNEL cells and nonuniform
K15 reactivity restricted to the basal layer of RLPs
(Figure 4 insets). By 24 hours, clusters of apoptotic
cells primarily within the immediate suprabasal layer
of most RLPs (80%) were observed by routine his-
tology and conﬁrmed by TUNEL staining (Figure 4).
This was associated with markedly diminished immu-
noreactivity for RLP K15 in adjacent sections. With
TNF- alone, TUNEL positivity was restricted to
single cells rather than cell clusters, whereas TNF-
and IL-1 in combination produced more prominent
clusters of TUNEL cells within RLPs. RLP-associ-
ated patterns of apoptosis and K15 loss were remark-
ably similar to those documented in GVHD animals
(Figure 3). Explants cultured in IL-1 or medium
alone failed to show pathologic alterations in K15
distribution or TUNEL staining within RLPs at any
time point evaluated.
DISCUSSION
We have used sequential evaluation of murine
tongue to better deﬁne speciﬁc sites of epithelial tar-
geting in experimental GVHD. RLPs, structures sim-
ilar to human epidermal rete ridges, were found to be
sites of selective inﬁltration by allostimulated CD4T
cells, as deﬁned by V8-speciﬁc mAb (in the B6 3
BALB.B model). Basal epithelium forming RLPs, but
not intervening cells, was shown for the ﬁrst time to
express high levels of immunohistochemically detect-
able K15, a feature shared with GVHD target cells in
the basal layer of human epidermal rete ridges. More-
over, epithelial target cell injury in early experimental
GVHD results in loss of K15 reactivity and induction
of apoptosis preferentially within RLPs. Finally, in a
model of murine lingual organ culture, cytokines of
established importance in GVHD pathogenesis were
capable of inducing GVHD-like alterations within
RLP target sites.
In 1985, Sale et al. [4], using morphometric ap-
proaches, made the seminal observation that rete ridge
keratinocytes may represent preferred targets in cuta-
neous GVHD. They subsequently hypothesized that
similar cell populations restricted to ﬁliform papillae
of the tongue [5] may also constitute GVHD targets.
Figure 4. Cytokine-mediated RLP cytotoxicity using an in vitro lingual organ culture model (incubation time, 24 hours). Note the loss of K15
immunoreactivity in RLPs after incubation with TNF- and with IL-1  TNF- (inset in IL-1  TNF-/K15 panel, represents an 8-hr
time point; note at this earlier time point the subtle diminution of K15 immunoreactivity). TUNEL-positive cells in adjacent sections of
explants incubated with TNF- and IL-1  TNF- were restricted to suprabasal regions of RLPs (arrows) (inset in IL-1  TNF-/
TUNEL panel; 8-hour time point demonstrating early apoptosis affecting a single cell within the basal layer [arrow]). Whereas explants
incubated with IL-1 or medium alone were indistinguishable from normal lingual mucosa by K15 and TUNEL immunohistochemistry, those
exposed to TNF- and IL-1  TNF- showed patterns of immunoreactivity remarkably similar to those of experimental GVHD (see Figure
3). H&E indicates hematoxylin and eosin.
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Although it is generally accepted that tissue-associated
homing to skin, liver, and gut is characteristic of
GVHD, the notion of target cell heterogeneity within
these tissues is only beginning to be elucidated. Squa-
mous epithelium contains cells representative of both
hematopoietic (eg, Langerhans cells) and nonhemato-
poietic (eg, epithelial cells) lineages. BMT recipient
mice chimeric for selected compartments of the epi-
thelial layer (hematopoietic versus nonhematopoietic)
have been used in an effort to address this issue.
Korngold and Sprent [33] used a CD8 T cell–medi-
ated B10.BR3 CBA miHA-disparate model in which
reirradiated chimeric transplant recipients demon-
strated signiﬁcantly diminished GVHD when donor
miHAs were expressed exclusively by the hematopoi-
etic compartment. The importance of the nonhema-
topoietic compartment in GVHD development also
has been observed recently in a CD4-mediated miHA
model (B6 3 BALB.B; S.C. Jones, unpublished data,
2003). Teshima et al. [30], however, evaluated bone
marrow chimeras in which either MHC class I or II
alloantigen was expressed exclusively by hematopoi-
etic cells, including antigen-presenting cells, and
found that acute GVHD does not require alloantigen
expression on host target epithelium. Although these
results may reﬂect targeting differences involving
miHA versus MHC, they provide evidence that early
cellular targeting is likely to be focused at speciﬁc cell
types within the epithelial layer.
RLPs of murine dorsal tongue are potentially rel-
evant to mechanisms involving both primary hemato-
poietic and nonhematopoietic targeting. This is in
part because the nonhematopoietic elements (RLP
epithelial cells) are now shown to be (1) phenotypi-
cally distinctive and separable with respect to K15
expression, (2) sites of preferential inﬁltration by an
allospeciﬁc V subpopulation of effector T cells, and
(3) target regions for apoptotic injury and loss of K15
immunoreactivity. However, it is also of interest that
MHC class II–positive dendritic cells of hematopoi-
etic origin are often localized within the suprabasal
layers of the RLP, but not within the intervening
epithelial domains (Figure 1A inset). In this regard,
the possibility that RLPs may serve as microenviron-
ments conducive to localized immune-mediated injury
is fortiﬁed by recent documentation that in GVHD,
these regions selectively express vascular cell adhesion
molecule-1 [6], a molecule that mediates both adhe-
sive and co-stimulatory events relevant to allostimu-
lated T cells [34-36].
Bickenback [11] has demonstrated that basal cells
in murine lingual RLPs have features of epithelial
stem cells. Lyle et al. [16] have shown that K15 may
deﬁne cells with characteristics of stem cells in the
bulge region of human follicular epithelium. Although
speculation exists regarding whether epithelial stem
cells in epidermis, hair follicles, and tongue epithe-
lium are primarily targeted in GVHD [37], their lo-
calization in GVHD target sites [11,38] now known in
murine tissues to harbor potentially overlapping sub-
populations of K15-reactive cells adds additional
strength to this possibility. On stimulation or injury,
epithelial stem cells are capable of a rapid proliferative
burst [10,39]. Proliferating (activated) epithelial cells
show diminished expression for K15 [17,40], and ep-
ithelial proliferation is an early response in GVHD
[41]. In addition, TNF- has been shown to suppress
K15 messenger RNA expression in an immortalized
human keratinocyte line [40]. Thus, the loss of K15
expression observed by immunohistochemistry, al-
though it indicates immunopathology that preferen-
tially affects RLP, may represent the effects of apo-
ptosis, epithelial activation/proliferation in response
to injury, or cytokine-mediated suppression—either
singly or in combination.
In murine GVHD models, both TNF- and
IL-1 are believed to play important roles in disease
evolution [30,42]. Inhibition of TNF- and IL-1, or
of TNF- alone, may signiﬁcantly ameliorate or even
prevent disease [15,30,43]. TNF- interacts with the
TNF-RI receptor that contains a death domain capa-
ble of inducing apoptosis in many cell types [44],
including murine squamous epithelium [45]. In this
study, we examined the hypothesis that one or both of
these cytokines could produce pathologic lesions that
preferentially affect RLPs and, thus, resemble those
documented in experimental GVHD. Our data sug-
gest that TNF- alone, and, to a greater extent, in
combination with IL-1, is capable of producing
RLP-directed pathology that has signiﬁcant qualita-
tive overlap with the phenotype of epithelial target
injury seen in experimental disease. Factors other than
cytokines, including the Fas/Fas ligand and perforin/
granzyme pathways, may also play roles in RLP-di-
rected target cell injury in GVHD, and these possi-
bilities require further study. However, our ﬁndings
support an important role for TNF- and IL-1 in
inducing RLP-directed epithelial target cell injury and
thus are in keeping with similar in vivo results impli-
cating these cytokines as key mediators of epithelial
pathology [30].
In summary, microanatomically and antigenically
distinctive lingual epithelial cells represent preferred
sites of targeting in experimental murine GVHD.
Similar targeting sites based on K15 expression within
epidermis may also exist, accounting for focality of
apoptotic injury. Cytokines relevant to GVHD are
capable of selectively affecting the same epithelial do-
mains that are vulnerable in experimental disease. The
ability to differentiate target epithelial cells and to
study them in in vitro models relevant to human
disease should now enable translational approaches
that will deﬁne and inhibit pathways of target cell
apoptosis in GVHD.
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